Infinity Neuro
Generated 5/9/2026
Executive Summary
Infinity Neuro is a private medical device company headquartered in Lake Forest, California, with additional operations in Suzhou, China. Founded in 2020, the company is dedicated to developing and commercializing innovative neurovascular devices for the treatment of ischemic and hemorrhagic stroke. Its leadership team brings over 50 years of combined industry experience in device development, regulatory strategy, and global commercialization. While the company has not publicly disclosed total funding, stage, or specific pipeline details, its focus on a high-need therapeutic area and experienced management suggests potential for growth. The company operates in the competitive neurovascular space, where technological advancements and regulatory approvals drive value. As a private entity, Infinity Neuro may seek partnerships or additional financing to advance its product candidates toward clinical validation and market entry.
Upcoming Catalysts (preview)
- TBDFirst clinical data readout for lead neurovascular device40% success
- TBDFDA 510(k) clearance or CE marking for a stroke treatment device35% success
- TBDStrategic partnership or licensing deal with a larger medical device company50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)